1-8 of 8
Maria Rosaria Rizzo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?

Free
Celestino Sardu, Nunzia D’Onofrio, Maria Luisa Balestrieri, Michelangela Barbieri, Maria Rosaria Rizzo, Vincenzo Messina, Paolo Maggi, Nicola Coppola, Giuseppe Paolisso, Raffaele Marfella
Journal: Diabetes Care
Diabetes Care 2020;43(7):1408–1415
https://doi.org/10.2337/dc20-0723
Published: 19 May 2020
View articletitled, Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control?
Open the PDF for Outcomes in Patients With Hyperglycemia Affected by COVID-19: Can We Do More on Glycemic Control? in another window
Journal Articles

Effects of Metformin Therapy on Coronary Endothelial Dysfunction in Patients With Prediabetes With Stable Angina and Nonobstructive Coronary Artery Stenosis: The CODYCE Multicenter Prospective Study

Free
Celestino Sardu, Pasquale Paolisso, Cosimo Sacra, Ciro Mauro, Fabio Minicucci, Michele Portoghese, Maria Rosaria Rizzo, Michelangela Barbieri, Ferdinando Carlo Sasso, Nunzia D’Onofrio, Maria Luisa Balestrieri, Paolo Calabrò, Giuseppe Paolisso, Raffaele Marfella
Journal: Diabetes Care
Diabetes Care 2019;42(10):1946–1955
https://doi.org/10.2337/dc18-2356
Published: 22 February 2019
View articletitled, Effects of Metformin Therapy on Coronary Endothelial Dysfunction in Patients With Prediabetes With Stable Angina and Nonobstructive Coronary Artery Stenosis: The CODYCE Multicenter Prospective Study
Open the PDF for Effects of Metformin Therapy on Coronary Endothelial Dysfunction in Patients With Prediabetes With Stable Angina and Nonobstructive Coronary Artery Stenosis: The CODYCE Multicenter Prospective Study in another window
Journal Articles

Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35: 2076–2082

Open Access
Maria Rosaria Rizzo, Michelangela Barbieri, Raffaele Marfella, Giuseppe Paolisso
Journal: Diabetes Care
Diabetes Care 2014;37(2):587–588
https://doi.org/10.2337/dc14-er02a
Published: 11 January 2014
View articletitled, Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35: 2076–2082
Open the PDF for Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35: 2076–2082 in another window
Journal Articles

Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082

Open Access
Maria Rosaria Rizzo, MD, PHD, Michelangela Barbieri, MD, PHD, Raffaele Marfella, MD, PHD, Giuseppe Paolisso, MD, PHD
Journal: Diabetes Care
Diabetes Care 2013;36(1):e13
https://doi.org/10.2337/dc12-1436
Published: 11 December 2012
View articletitled, Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082
Open the PDF for Response to Comment on: Rizzo et al. Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of Dipeptidyl Peptidase-IV Inhibition. Diabetes Care 2012;35:2076–2082 in another window
Journal Articles

Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of dipeptidyl peptidase-IV inhibition

Open Access
Maria Rosaria Rizzo, MD, Michelangela Barbieri, MD, Raffaele Marfella, MD, Giuseppe Paolisso, MD
Journal: Diabetes Care
Diabetes Care 2012;35(10):2076–2082
https://doi.org/10.2337/dc12-0199
Published: 11 September 2012
View articletitled, Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of dipeptidyl peptidase-IV inhibition
Open the PDF for Reduction of Oxidative Stress and Inflammation by Blunting Daily Acute Glucose Fluctuations in Patients With Type 2 Diabetes: Role of dipeptidyl peptidase-IV inhibition in another window
Includes: Supplementary data
Journal Articles

Relationships Between Daily Acute Glucose Fluctuations and Cognitive Performance Among Aged Type 2 Diabetic Patients

Open Access
Maria Rosaria Rizzo, MD, PHD, Raffaele Marfella, MD, PHD, Michelangela Barbieri, MD, PHD, Virginia Boccardi, MD, Francesco Vestini, MD, Biagio Lettieri, MD, Silvestro Canonico, MD, Giuseppe Paolisso, MD, PHD
Journal: Diabetes Care
Diabetes Care 2010;33(10):2169–2174
https://doi.org/10.2337/dc10-0389
Published: 23 June 2010
View articletitled, Relationships Between Daily Acute Glucose Fluctuations and Cognitive Performance Among Aged Type 2 Diabetic Patients
Open the PDF for Relationships Between Daily Acute Glucose Fluctuations and Cognitive Performance Among Aged Type 2 Diabetic Patients in another window
Journal Articles

Bariatric Surgery Reduces Oxidative Stress by Blunting 24-h Acute Glucose Fluctuations in Type 2 Diabetic Obese Patients

Open Access
Raffaele Marfella, MD, PHD, Michelangela Barbieri, MD, PHD, Roberto Ruggiero, MD, Maria Rosaria Rizzo, MD, PHD, Rodolfo Grella, MD, PHD, Anna Licia Mozzillo, MD, Ludovico Docimo, MD, Giuseppe Paolisso, MD, PHD
Journal: Diabetes Care
Diabetes Care 2010;33(2):287–289
https://doi.org/10.2337/dc09-1343
Published: 04 November 2009
View articletitled, Bariatric Surgery Reduces Oxidative Stress by Blunting 24-h Acute Glucose Fluctuations in Type 2 Diabetic Obese Patients
Open the PDF for Bariatric Surgery Reduces Oxidative Stress by Blunting 24-h Acute Glucose Fluctuations in Type 2 Diabetic Obese Patients in another window
Journal Articles

Safety of Type 2 Diabetes Treatment With Repaglinide Compared With Glibenclamide in Elderly People : A randomized, open-label, two-period, cross-over trial

Free
Giuseppe Papa, MD, Viviana Fedele, MD, Maria Rosaria Rizzo, MD, Marisa Fioravanti, MD, Carmelo Leotta, MD, Sebastiano Bruno Solerte, MD, Francesco Purrello, MD, Giuseppe Paolisso, MD
Journal: Diabetes Care
Diabetes Care 2006;29(8):1918–1920
https://doi.org/10.2337/dc05-2495
Published: 01 August 2006
View articletitled, Safety of Type 2 Diabetes Treatment With Repaglinide Compared With Glibenclamide in Elderly People : A randomized, open-label, two-period, cross-over trial
Open the PDF for Safety of Type 2 Diabetes Treatment With Repaglinide Compared With Glibenclamide in Elderly People : A randomized, open-label, two-period, cross-over trial in another window